337 related articles for article (PubMed ID: 16542792)
1. Nasopharyngeal carcinoma treated by radical radiotherapy alone: Ten-year experience of a single institution.
Yi JL; Gao L; Huang XD; Li SY; Luo JW; Cai WM; Xiao JP; Xu GZ
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):161-8. PubMed ID: 16542792
[TBL] [Abstract][Full Text] [Related]
2. Is elective irradiation to the lower neck necessary for N0 nasopharyngeal carcinoma?
Gao Y; Zhu G; Lu J; Ying H; Kong L; Wu Y; Hu C
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1397-402. PubMed ID: 20044215
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of brachytherapy and fractionated stereotactic radiotherapy boost for persistent nasopharyngeal carcinoma.
Yau TK; Sze WM; Lee WM; Yeung MW; Leung KC; Hung WM; Chan WI
Head Neck; 2004 Dec; 26(12):1024-30. PubMed ID: 15390194
[TBL] [Abstract][Full Text] [Related]
4. Brachytherapy boost for T1/T2 nasopharyngeal carcinoma.
Yeo R; Fong KW; Hee SW; Chua ET; Tan T; Wee J
Head Neck; 2009 Dec; 31(12):1610-8. PubMed ID: 19536853
[TBL] [Abstract][Full Text] [Related]
5. High-dose-rate intracavitary brachytherapy boost for early T stage nasopharyngeal carcinoma{private}.
Leung TW; Wong VY; Sze WK; Lui CM; Tung SY
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):361-7. PubMed ID: 17892917
[TBL] [Abstract][Full Text] [Related]
6. Excellent local control with stereotactic radiotherapy boost after external beam radiotherapy in patients with nasopharyngeal carcinoma.
Hara W; Loo BW; Goffinet DR; Chang SD; Adler JR; Pinto HA; Fee WE; Kaplan MJ; Fischbein NJ; Le QT
Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):393-400. PubMed ID: 18164839
[TBL] [Abstract][Full Text] [Related]
7. Sequential external beam radiotherapy and high-dose-rate intracavitary brachytherapy in T1 and T2 nasopharyngeal carcinoma: an evaluation of long-term outcome.
Thiagarajan A; Lin K; Tiong CE; Tan LK; Loh TK; Goh BC; Lu JJ
Laryngoscope; 2006 Jun; 116(6):938-43. PubMed ID: 16735885
[TBL] [Abstract][Full Text] [Related]
8. Preliminary experience in HDR brachytherapy for 72 nasopharyngeal carcinoma patients.
Gao L; Xu GZ; Yin WB; Yan JH; Cai WM; Gu XZ
Chin Med J (Engl); 1993 Jun; 106(6):467-70. PubMed ID: 8222900
[TBL] [Abstract][Full Text] [Related]
9. Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma.
Lu JJ; Kong L; Shakespeare TP; Loh KS; Zhang Q; Tan KS; Lee KM
Oral Oncol; 2008 Jul; 44(7):703-9. PubMed ID: 18061528
[TBL] [Abstract][Full Text] [Related]
10. Nasopharyngeal carcinoma with cranial nerve palsy: the importance of MRI for radiotherapy.
Chang JT; Lin CY; Chen TM; Kang CJ; Ng SH; Chen IH; Wang HM; Cheng AJ; Liao CT
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1354-60. PubMed ID: 16297716
[TBL] [Abstract][Full Text] [Related]
11. Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma: an evaluation of response and toxicity.
Lu JJ; Shakespeare TP; Thiagarajan A; Zhang X; Liang L; Tan S
Laryngoscope; 2005 May; 115(5):806-10. PubMed ID: 15867644
[TBL] [Abstract][Full Text] [Related]
12. [Short-and long-term therapeutic effects of brachytherapy on intracavitary residual tumor in 563 nasopharyngeal carcinoma (NPC) patients].
Cao X; Chen K; He Z
Zhonghua Zhong Liu Za Zhi; 1998 Mar; 20(2):146-7. PubMed ID: 10920969
[TBL] [Abstract][Full Text] [Related]
13. Dose-response relationship of nasopharyngeal carcinoma above conventional tumoricidal level: a study by the Hong Kong nasopharyngeal carcinoma study group (HKNPCSG).
Teo PM; Leung SF; Tung SY; Zee B; Sham JS; Lee AW; Lau WH; Kwan WH; Leung TW; Chua D; Sze WM; Au JS; Yu KH; O SK; Kwong D; Yau TK; Law SC; Sze WK; Au G; Chan AT
Radiother Oncol; 2006 Apr; 79(1):27-33. PubMed ID: 16626829
[TBL] [Abstract][Full Text] [Related]
14. High dose rate brachytherapy boost for primary nasopharyngeal carcinoma: preliminary results of an ongoing prospective study.
Malde R; Agarwal JP; Laskar SG; Gupta T; Dinshaw K
Bull Cancer; 2005 Jul; 92(7):E45-50. PubMed ID: 16122998
[TBL] [Abstract][Full Text] [Related]
15. [Application of interstitial brachytherapy via parapharynx involvement transnasal approach to enhance dose in radiotherapy for nasopharyngeal carcinoma].
Chen MY; Cao XP; Sun R; Hua YJ; Li AJ; Liu YY; Ouyang Y; Guo L; Chen QY; Hong MH
Ai Zheng; 2007 May; 26(5):513-8. PubMed ID: 17672943
[TBL] [Abstract][Full Text] [Related]
16. Four year clinical statistics of iridium-192 high dose rate brachytherapy.
Shigehara K; Mizokami A; Komatsu K; Koshida K; Namiki M
Int J Urol; 2006 Feb; 13(2):116-21. PubMed ID: 16563134
[TBL] [Abstract][Full Text] [Related]
17. Improved outcome of nasopharyngeal carcinoma treated with conventional radiotherapy.
Palazzi M; Guzzo M; Tomatis S; Cerrotta A; Potepan P; Quattrone P; Cantù G
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1451-8. PubMed ID: 15590176
[TBL] [Abstract][Full Text] [Related]
18. Nasopharyngeal intracavitary brachytherapy: the controversy of T2b disease.
Leung TW; Tung SY; Wong VY; Sze WK; Lui CM; Wong FC; Lee AS; O SK
Cancer; 2005 Oct; 104(8):1648-55. PubMed ID: 16118806
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcome in patients with prostate cancer treated with external beam radiotherapy and high dose-rate iridium 192 brachytherapy boost: a 6-year follow-up.
Kälkner KM; Wahlgren T; Ryberg M; Cohn-Cedermark G; Castellanos E; Zimmerman R; Nilsson J; Lundell M; Fowler J; Levitt S; Hellström M; Nilsson S
Acta Oncol; 2007; 46(7):909-17. PubMed ID: 17917823
[TBL] [Abstract][Full Text] [Related]
20. High dose rate afterloading intraluminal brachytherapy for advanced inoperable rectal carcinoma.
Hoskin PJ; de Canha SM; Bownes P; Bryant L; Glynne Jones R
Radiother Oncol; 2004 Nov; 73(2):195-8. PubMed ID: 15542167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
